You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 132 No. 4, April 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  THE CUTTING EDGE
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (16)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Pseudallescheria boydii in an Immunocompromised Host

Successful Treatment With Débridement and Itraconazole

Tamra A. Ruxin, MD; William D. Steck, MD; Thomas N. Helm, MD; Wilma F. Bergfeld, MD; Brian J. Bolwell, MD

Arch Dermatol. 1996;132(4):382-384.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

REPORT OF A CASE

A 63-year-old man with acute myelogenous leukemia was admitted for induction chemotherapy with cytosine arabinoside and daunorubicin. Therapy with ciprofloxacin, acyclovir, and amphotericin B was prophylactically initiated when chemotherapy was begun. The patient complained of mild tenderness at the base of the right great toe. He believed that the lesion developed after bruising his foot with his intravenous medication stand while walking.

On the day of consultation, the erythema and swelling that were present for 2 days were spreading and a 0.5 cm, centrally necrotic, intact blister was noted. This was coincident with low-grade fever. Laboratory studies showed the following values: leukocytes, 0.5 x109/L, with 0.1 neutrophils; platelets, 21x109/L; and hemoglobin, 108 g/L. Ciprofloxacin therapy was discontinued. Therapy with vancomycin, tobramycin, and ceftazidine was initiated to treat a suspected infection. A potassium hydroxide preparation and fungal culture of the blister top were performed and . . . [Full Text PDF of this Article]


Author Affiliations

The Cleveland Clinic Foundation, Cleveland, Ohio (Drs Ruxin, Steck, Bergfeld and Bolwell), and the State University of New York at Buffalo (Dr Helm)



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.